Reduced plasma orexin-A levels in patients with bipolar disorder

Código QR

Reduced plasma orexin-A levels in patients with bipolar disorder

Shoko Tsuchimine,1 Kotaro Hattori,1 Miho Ota,1 Shinsuke Hidese,1 Toshiya Teraishi,1 Daimei Sasayama,1 Hiroaki Hori,1 Takamasa Noda,2 Sumiko Yoshida,2 Fuyuko Yoshida,1 Hiroshi Kunugi11Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Orexin-A Plasma Schizophrenia Major depressive disorder Bipolar disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/6823340e0a4342fb8ccdaf4e55c9efe0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Borjanka Batinic, et al.
Publicado: (2021)

Comparing the Self- and External Assessment Versions of the HCL-33 as Screening Instruments for Bipolar Disorder in Older Depressed Patients
por: Xinqiao Zhang, et al.
Publicado: (2021)

When should a psychiatrist remember to test homocysteine levels? - a literature review
por: Nowak Katarzyna, et al.
Publicado: (2021)

Tumor cell apoptosis mediated by the orexins
por: A. S. Diatlova, et al.
Publicado: (2021)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Association of carbohydrate and fatty acid intake with anthropometric parameters in subjects with schizophrenia and bipolar disorders
por: Santillana T,Natalia, et al.
Publicado: (2016)

A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness
por: Kopelowicz A, et al.
Publicado: (2017)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
por: Bo Q, et al.
Publicado: (2019)

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia
por: Puspitasari IM, et al.
Publicado: (2020)

The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni P, et al.
Publicado: (2021)

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura R, et al.
Publicado: (2017)

Lithium Preparations in Psychiatry, Addiction Medicine and Neurology (To the 70th Anniversary of John Cade’s Discovery). Part I. History
por: Roman A. Bekker, et al.
Publicado: (2019)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Editorial: The Role of Resilience and the Interplay Between Genetics and Environment in Bipolar Disorder
por: Bianca Pfaffenseller, et al.
Publicado: (2021)

Plasma Cell-Free DNA Methylomics of Bipolar Disorder With and Without Rapid Cycling
por: Ada Man-Choi Ho, et al.
Publicado: (2021)

Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes <i>BSN</i> and <i>PCLO</i> in Schizophrenia and Bipolar Disorder
por: Chia-Hsiang Chen, et al.
Publicado: (2021)

Research progress on the mechanism of orexin in pain regulation in different brain regions
por: Kang Xianhui, et al.
Publicado: (2021)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts RJ, et al.
Publicado: (2016)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Hyunju Lee, et al.
Publicado: (2021)

Bipolar disorders
Publicado: (1999)

Pattern of burden on the family of patients with schizophrenia and bipolar disorder: A comparative study
por: Khurshida Khatoon, et al.
Publicado: (2021)

Enfermedades afectivas y actividad solar: Seguimiento a 16 años
por: IVANOVIC-ZUVIC,FERNANDO, et al.
Publicado: (2010)

Gene expression-based biological test for major depressive disorder: an advanced study
por: Watanabe S, et al.
Publicado: (2017)

Overcoming barriers to effective management of tardive dyskinesia
por: Caroff SN
Publicado: (2019)

International journal of bipolar disorders
Publicado: (2013)

Evaluación de la calidad de vida de pacientes bipolares chilenos: propiedades psicométricas y utilidad diagnóstica de la versión chilena del cuestionario Quality of Life Bipolar Disorder (QoL.BD-CL)
por: Morgado,Carolina, et al.
Publicado: (2015)

Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders
por: Yang T, et al.
Publicado: (2021)

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
por: Grambal A, et al.
Publicado: (2016)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
por: Park YM, et al.
Publicado: (2016)

Characteristics of auditory hallucinations in Indian patients with schizophrenia and bipolar affective disorder
por: Rajesh S Dhakne, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin N, et al.
Publicado: (2020)

Development and Structures of Trialogue for Bipolar Disorders in Germany and Guidelines of the German Society for Bipolar Disorders
por: Martin Schaefer, et al.
Publicado: (2021)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic M, et al.
Publicado: (2018)

The Prevalence of Sarcopenia in Bipolar Disorder
por: Bulbul F, et al.
Publicado: (2020)

CLINICAL COURSE AND DIAGNOSTICS OF NON-PSYCHOTIC AFFECTIVE DISORDERS BASED ON LONG-TERM CATAMNESIS
por: V. S. Sobennikov, et al.
Publicado: (2015)

The German research consortium for the study of bipolar disorder (BipoLife): a magnetic resonance imaging study protocol
por: Christoph Vogelbacher, et al.
Publicado: (2021)

Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021)

Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder
por: Chen JX, et al.
Publicado: (2021)